Otrivin Gyermek (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin Gyermek, is an alpha‑2‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion in children by constricting blood vessels in the nasal mucosa. GNH USA supplies Otrivin Gyermek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin Gyermek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin Gyermek contains xylometazoline, an alpha‑2‑adrenergic agonist that acts on the nasal mucosal vasculature to reduce congestion.

- Common cold in children: temporary relief of nasal blockage caused by viral upper respiratory infection. - Allergic rhinitis in children: reduction of swelling and congestion due to seasonal allergens. - Sinusitis in children: helps ease nasal airflow by decongesting inflamed nasal passages. - Post‑operative nasal care: supports clearance of nasal passages after ENT procedures.

Adverse reactions to Otrivin Gyermek are generally mild and reversible.

Common Side Effects: - Burning or stinging sensation in the nose. - Nasal dryness or irritation. - Sneezing shortly after application. - Mild headache. - Transient taste disturbance.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe nosebleeds (epistaxis). - Allergic reactions such as rash, itching or swelling. - Hypertension exacerbation in susceptible individuals. - Rebound congestion with prolonged use beyond recommended duration.

Before using Otrivin Gyermek, consider the following safety measures:

- Age restriction: not for children under 2 years without medical advice. - Duration limit: limit use to 3‑5 days to avoid rebound congestion. - Pre‑existing conditions: use cautiously in patients with hypertension, heart disease, diabetes mellitus, or thyroid disorders. - Concomitant nasal medications: avoid using other topical decongestants simultaneously. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines that affect vascular tone or blood pressure.

Major Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): risk of excessive vasoconstriction. - Systemic sympathomimetics (e.g., pseudoephedrine): additive hypertensive effect.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may reduce efficacy of blood‑pressure control. - Other intranasal decongestants: increased risk of local irritation and rebound congestion. - Topical corticosteroids: monitor for enhanced mucosal dryness. - Herbal supplements containing ephedra: potential additive sympathomimetic action.